Skip to Content

Spinal Tumor Clinical Trials

The following trials for the treatment of various spinal cancer conditions are available for your participation. Click on the study number to view details of eligibility criteria. 

Last updated 10/15/13 

CERN09-02:  Phase II Trial of Carboplatin and Bevacizumab for the Treatment of Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial and Spinal cord Ependymoma in Adults 
Principal Investigator: Mark R. Gilbert, M.D.

The goal of this clinical research study is to learn if the combination of bevacizumab and carboplatin can help to control recurrent ependymoma. The safety of this drug combination will also be studied. 

Treatment at MD Anderson

Brain tumors, spinal tumors and skull base tumors are treated in our:

Diseases We Treat

Related Departments

Follow Us



© 2015 The University of Texas MD Anderson Cancer Center